Unlike selective estrogen receptor degraders (SERDs), which only inhibit ER activity, ARV-471 leads to the complete degradation of the estrogen receptor, preventing estrogen-dependent signaling and tumor growth. This evidence concerns the gene ESR1 and neoplasm.